VTAK logo

Catheter Precision, Inc. Stock Price

NYSEAM:VTAK Community·US$2.5m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

VTAK Share Price Performance

US$1.43
-5.60 (-79.66%)
US$1.43
-5.60 (-79.66%)
Price US$1.43

VTAK Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Slight risk with mediocre balance sheet.

4 Risks
0 Rewards

Catheter Precision, Inc. Key Details

US$730.0k

Revenue

US$54.0k

Cost of Revenue

US$676.0k

Gross Profit

US$22.9m

Other Expenses

-US$22.2m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-12.76
92.60%
-3,039.86%
24.8%
View Full Analysis

About VTAK

Founded
n/a
Employees
22
CEO
David Jenkins
WebsiteView website
www.catheterprecision.com

Catheter Precision, Inc. designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States. The company’s lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also offers LockeT, a suture retention device that temporarily secure sutures and aid clinicians in locating and removing sutures. The company is based in Fort Mill, South Carolina.

Recent VTAK News & Updates

Recent updates

No updates